New Industry Benchmark! Peking University International Hospital Installs ZAP-X on site for Non-Invasive，High-Precision Radiotherapy

After calibrating the final set of parameters, installation of the ZAP-X Gyroscopic Radiosurgery Platform (hereinafter referred to as ZAP-X) at Peking University International Hospital (PKUIH) has been completed. Due to strong support from the Peking University Healthcare Group (PKU Healthcare), the hospital has integrated ZAP-X into its Cancer Center as part of its efforts to develop key specialty disciplines—an approach that reflects a commitment to aligning medical services with insurance services.

The introduction of this advanced equipment goes beyond a simple technology rollout. Driven by the leadership’s strategic vision and precise execution, it represents a landmark step in elevating the hospital’s diagnostic and treatment capabilities, enhancing patient care, and supporting the high-quality development of the broader medical field. It is a clear demonstration of the hospital’s determination and efficiency in building a world-class clinical facility.

Prior to the ZAP-X equipment arrival, Dr. Liang Jun, Conference Chair, Party Secretary, Executive Vice President, and Director of the Oncology Center at Peking University International Hospital, led a team to conduct comprehensive and meticulous supervision at the installation site. Dr. Liang Jun personally inspected preparatory measures, including site layout, equipment transport routes, and safety protocols. 

Aligning with the hospital's overall strategy of "Building a world-class hospital” and “leading healthcare reform," Dr. Liang Jun also meticulously planned each stage of the installation process and provided precise directives on critical points such as safety control, technological integration, and departmental coordination. He repeatedly emphasized that the installation of the ZAP-X marks a critical milestone for the hospital’s Cancer Center. The work, he stressed, must be guided by the principles of “safety first, strict adherence to standards, and continuous improvement”—delivering zero errors and meeting the highest benchmarks to ensure a solid foundation for future clinical applications.

The supervisory team included Yang Songlin, Director of the Medical Engineering Department; Wang Jidong, Director of the Radiotherapy Department; Xu Xiangsheng, Deputy Director of the Radiotherapy Department; Li Li, Deputy Director of the Oncology Department; Chen Xingyu, Chief Radiotherapy Technologist; and personnel from the BAHEAL MEDICAL team. Following Dr. Liang Jun's directives, the team discussed and refined the installation plan on-site, clarifying responsibilities for each department.

From mapping out the path for equipment disassembly and transport, to managing noise control during overnight work, to fine-tuning technical specifications—multiple teams came together in seamless coordination. The result was a collaborative model built on strong leadership, cross-department cooperation, and hospital-enterprise partnership, a true reflection of the organizational strength and unity driving the hospital’s major medical projects forward. To keep daily clinical operations running smoothly, the installation team followed leadership’s direction and worked through the night. After several days of focused, well-orchestrated effort, the full equipment installation was completed successfully, with every parameter meeting the initial requirements.

In regards to PKUIH’s future development, the successful installation of ZAP-X is a key achievement in implementing Dr. Liang Jun's plan for developing flagship disciplines and represents a strategic leap forward in perfecting the hospital's precision oncology system. The arrival of this equipment fills a critical gap in the hospital's capabilities for non-invasive precision radiation therapy for brain tumors. It complements the existing radiotherapy equipment, creating a comprehensive radiotherapy system covering tumors throughout the body, integrating both external and internal irradiation.

This will not only significantly enhance the hospital's ability to diagnose and treat difficult conditions like brain metastases and primary brain tumors, helping to establish a leading center for specialized brain tumor treatment in China, but also further consolidate the hospital's core position in the oncology field within the North Beijing area and nationwide. Furthermore, supported by this advanced equipment, the hospital can advance its clinical research and talent development, building a premium platform for international multi-center studies and accumulating evidence-based results in China, thereby accelerating the integrated development of medical treatment, education, and research.

For patients, the arrival of ZAP-X brings unprecedented new hope for treatment. As a revolutionary device in the field of global precision cranial radiation therapy, its pioneering features—including fully self-shielding design, submillimeter delivery accuracy, and a real-time imaging and dose monitoring system—enable the precise, non-invasive ablation of intracranial tumors while minimizing the risk of damage to critical healthy structures like the brainstem and optic nerves. This technological advantage effectively addresses the clinical challenges of traditional surgery (significant trauma), chemotherapy (difficulty penetrating the blood-brain barrier), and conventional radiotherapy (insufficient precision). It promises to significantly improve both the survival rates and quality of life for brain tumor patients, making cutting-edge non-invasive precision radiation therapy a truly accessible and beneficial medical treatment for patients.

Looking at the broader industry landscape, the installation of ZAP-X—spearheaded by the hospital's leadership—carries significant weight. The system's lightweight design, high precision, and ease of deployment offer a practical model that can be replicated and scaled across China's precision radiation therapy sector. This helps push the industry forward, shifting the focus from precision alone to a future centered on non-invasive solutions and wider patient access. At the same time, the strong hospital-enterprise partnership behind this project sets a new benchmark for how advanced medical equipment can be integrated into care. It supports the localization and industrial growth of cutting-edge radiotherapy technologies, brings China's capabilities more in line with global standards, and provides real momentum for closing regional gaps in healthcare resources—advancing the goals of the Healthy China 2030 initiative.

Moving forward under Dr. Liang Jun’s directives, Peking University International Hospital and BAHEAL MEDICAL will collaborate to move the project into clinical use. Next steps include fine-tuning the equipment, completing performance validation, training clinical staff, and finalizing regulatory approvals—all aimed at making ZAP-X available to patients as soon as possible. The hospital is committed to making the most of this technology, turning strategic vision into real-world benefits for patients. By providing more advanced diagnostic and treatment options and upholding a high standard of care, PKUIH looks to drive its own growth, contribute to progress across the industry, and stay true to its mission of protecting public health.